On September 16th, the Chengdu Medical City (Science and Technology Park) held a concentrated signing ceremony for the 2020 Chengdu Medical City project in Wenjiang District. Li Yi, Deputy Secretary of the Wenjiang District Committee, Lu Hongxing, Deputy District Mayor of the District Government, and Qin Baoping, Deputy District Level Leader, attended the signing ceremony.
The centralized signing ceremony for this project was attended by representatives from Raytec Biological Regenerative Medicine R&D and Production Base, Southern Medical University Biotechnology Research and Development Project, and Shanghai Newmai Innovation Medical Device R&D and Production Center. A total of 16 projects were signed, with a total investment of approximately 12.4 billion yuan. The contracted project involves multiple fields such as medical research and development, pharmaceutical equipment manufacturing, and medical big data. It has introduced cutting-edge technologies such as biological amniotic membrane regeneration and repair equipment, functional uterine repair materials, and Israeli micro injection needles, further improving the industrial ecosystem of Chengdu Medical City and enhancing its industrial level.
Raytec Biotechnology mainly focuses on the development and application of homologous regenerative repair materials such as biological amniotic membrane in ophthalmology, dentistry, orthopedics, etc. The company is the first wet biological amniotic membrane product in China. The company will build a research and production base for regenerative medicine in Chengdu Medical City, including 6 production lines for medical restorative medical devices in fields such as ophthalmology, dentistry, and orthopedics, and strive to achieve listing on the Science and Technology Innovation Board in Chengdu Medical City by 2023.
Speech by Lu Hongxing, Deputy District Mayor of Wenjiang District Government
Lu Hongxing, Deputy District Mayor of the District Government, delivered a speech introducing the favorable investment environment of Chengdu Medical City and warmly congratulating the signed project.
Lin Yongliang, Chairman of Raytec Biotechnology, and Wu Jia, Operations Director of Nanyi Huajun, delivered speeches as representatives of the contracted enterprises. They shared their experience and feelings of investing in Chengdu Medical City, affirmed its solid industrial foundation and ecosystem, and stated that they will accelerate project implementation, work together to promote the development of the health industry in Wenjiang, and help build a leading health industry highland in the western region.
